Resources & Support

Improve subject protection, operational efficiency and data quality while significantly reducing trial costs by decreasing or eliminating wasteful Source Data Verification (SDV).

Real-World Evidence (RWE) has become an integral component of drug and medical device development, as well as of Health Economics & Outcomes Research (HEOR). Serving as a complement to conventional randomized clinical trials (RCTs), Real-World Evidence collects supporting outcomes and safety data beyond RCTs, that provide a more comprehensive view of a product's real-life therapeutic and economic value to patients, payers, providers and sponsors. With the right data and analytics support, Real-World Evidence informs a common understanding of a drug or device efficacy and safety profile that is used by multiple healthcare stakeholders to drive decisions.

Built for medical monitors, developed for subject safety, loved by IT. PerkinElmer Signals^™ Medical Review empowers medical monitors to detect safety signals faster and reduce time to submission by combining innovative medical data review workflow with advanced analytics. All this on a secure cloud infrastructure.

Medical monitors need to:

• Easily find subjects of interest
• Quickly gain insights using powerful analytics
• Efficiently track their review progress

 

Our analytics solutions help companies find the balance between the clinical studies portfolio, resources and budget.

The PerkinElmer Clinical Data Review Solution provides the most effective way to perform in-stream review of study data, empowering clinical development teams to make smarter decisions faster.

Our Clinical Data Review solution provides Medical Monitors, Safety Review Teams, Biostatisticians, Data Managers, Pharmacologists, and others challenged with analyzing clinical data with a powerful and advanced analytics solution to overcome clinical data review challenges. The solution enhances medical review workflows, allowing organizations to make more informed decisions on the safety and efficacy of therapeutics earlier in development.

Our Risk-Based Monitoring Solution is the most effective way to leverage data-driven insights to optimize site performance while improving patient safety.

With our solution for risk-based monitoring, the effort spent on complete source-data verification can be significantly reduced. The resulting savings (in both time and costs) allows for better data analysis and better protection of subjects without multiplying costs.

Benefits of Risk-Based Monitoring include

• Quickly identify and track actions for high risk sites
• Reduce complexity by supporting multiple trial designs and data sources
• Optimize monitoring using adaptive risk models applied to historical study data

Our innovative solution for Pharmacovigilance replaces the reporting out of safety systems that leverage standard BI tools, breaking the query, wait, evaluate cycle.